Medicover AB (LTS:0RPS) Equity-to-Asset: 0.22 (As of Jun. 2026) — 21% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RPS Medicover AB LTS:0RPS
88 GF Score
Price kr248.50
GF Value kr233.37
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medicover AB Equity-to-Asset?

Medicover AB LTS:0RPS 88 Equity-to-Asset is 0.22 as of Jun. 2026, which is 21% below its 10-year median of 0.28. GuruFocus rates LTS:0RPS with a GF Score™ of 88/100 and a GF Value™ of kr233.37 (Fairly Valued). The stock has 6 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Medicover AB ranks worse than 80.38% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Medicover AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr5,885 Mil. Medicover AB's Total Assets for the quarter that ended in Jun. 2026 was kr26,703 Mil. Therefore, Medicover AB's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.22.

The historical rank and industry rank for Medicover AB's Equity-to-Asset or its related term are showing as below:

LTS:0RPS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.2   Med: 0.28   Max: 0.65
Current: 0.22

During the past 12 years, the highest Equity to Asset Ratio of Medicover AB was 0.65. The lowest was 0.20. And the median was 0.28.

LTS:0RPS's Equity-to-Asset is ranked worse than
80.38% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 0.49 vs LTS:0RPS: 0.22

Medicover AB  (LTS:0RPS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Medicover AB Equity-to-Asset Related Terms


Medicover AB Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Medicover AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Equity-to-Asset Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.26 0.26 0.22 0.22

Medicover AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.22 0.22 0.23 0.22

LTS:0RPS vs HCA, THC, EHC: Equity-to-Asset Comparison

For the Medical Care Facilities subindustry, Medicover AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Equity-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Medicover AB's Equity-to-Asset falls into.


LTS:0RPS
88GF Score
Medicover AB LTS:0RPS
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Medicover AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=5798.099/26345.005
=0.22

Medicover AB's Equity to Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

Equity to Asset (Q: Jun. 2026 )=Total Stockholders Equity/Total Assets
=5884.701/26702.598
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.22 mean?
Medicover AB (LTS:0RPS) has a Equity-to-Asset of 0.22 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Medicover AB and its competitors. This is 21% below median its historical median of 0.28. Over the past decade, Medicover AB's Equity-to-Asset has ranged from 0.20 to 0.65. According to the industry distribution chart, Medicover AB ranks #549 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 80.4%.
Is Medicover AB's Equity-to-Asset too high?
Medicover AB's current Equity-to-Asset of 0.22 is 21% below median its 10-year median of 0.28. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 0.65. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Medicover AB's value of 0.22 is 55.1% below this industry median. Based on the distribution chart, Medicover AB ranks #549 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medicover AB has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #549 out of 683 companies for Equity-to-Asset. This places Medicover AB in the lower half of its industry. The industry median Equity-to-Asset is 0.49. Medicover AB's value of 0.22 is 55.1% below this benchmark. Historically, Medicover AB's own Equity-to-Asset has ranged from 0.20 to 0.65 over the past decade. While the company's 10-year median is 0.28 vs. the industry median of 0.49, Medicover AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicover AB's current Equity-to-Asset of 0.22 is 55.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current Equity-to-Asset is 0.22, which is 21% below median its own 10-year median of 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.37, compared to a current price of kr248.50 — trading 6.5% above its estimated fair value. The current Equity-to-Asset is 0.22, which is 21% below median its 10-year median of 0.28 and 55.1% below the Healthcare Providers & Services industry median of 0.49. Medicover AB's overall GF Score™ is 88/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Equity-to-Asset is 0.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued. The current stock price of kr248.50 is trading 6.5% above its estimated GF Value™ of kr233.37. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Equity-to-Asset: 0.22 (21% below median its 10-year median of 0.28)
  • GF Value™: kr233.37 vs. price of kr248.50 (6.5% above fair value)
  • GF Score™: 88/100 with 6 warning signs
  • Industry Position: 55.1% below the Healthcare Providers & Services median (#549 of 683)

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
88GF Score

Get the complete analysis for LTS:0RPS

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr248.50
Price
kr233.37
GF Value